About
About journalGoals and objectivesEditorial councilContacts
ArchiveSubscription
To Authors
Copyright agreementProcedure for reviewingRequirements for publicationsSend articlePrivacy DeclarationConflicts of Interest DeclarationCriteria for authorship
Ethical Standards
ISSN 2073–4034
eISSN 2414–9128
About
About journalGoals and objectivesEditorial councilContacts
ArchiveSubscription
To Authors
Copyright agreementProcedure for reviewingRequirements for publicationsSend articlePrivacy DeclarationConflicts of Interest DeclarationCriteria for authorship
Ethical Standards
Logout
Year
202420232022202120202019201820162015201420132012201120102009200820072006200520042003200220012000
Edition number
№s5-17№20 (353)№19 (352)№14 (347)№18 (351)№17 (350)№16 (349)№s4-17№13 (346)№s3-17№11 (344)№12 (345)№10 (343)№КР2№9 (342)№8 (341)№КР1№7 (340)№6 (339)№5 (338)№4 (337)№s2-17№2 (335)№s1-17№3 (336)№1 (334)

№15 (348) / 2017

Z.A. Zalyalova (1, 2), I.F. Khafizova (1), Z.G. Khayatova (1)
PATHOPHYSIOLOGICAL BASES OF REHABILITATION IN CERVICAL DYSTONY
7-15
P.S. Laguta
ACETYLSALICYLIC ACID AND PRIMARY PREVENTION: NEW OPPORTUNITIES
16-23
O.D. Ostroumova (1, 2), A.I. Kochetkov (1), V.V. Vikentyev (1), E.E. Pavleyeva (1)
POSSIBILITIES OF AMLODIPINE/LISINOPRIL FIXED-DOSE COMBINATION IN REAL CLINICAL PRACTICE
24-30
N.P. Lyamina, E.S. Karpova
CARDIOVASCULAR SAFETY AND EFFICACY OF CELECOXIB: FOCUS ON TREATMENT AND CARDIOSOMATIC REHABILITATION
31-36
S.G. Kanorsky, A.F. Sereda
THE USE OF STATINES IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION
37-42
N.V. Korneyeva (1), S.L. Zharskiy (1), B.P. Shevtsov (2), A.O. Scherban (1), N.K. Fisenko (1)
COMPARATIVE ANALYSIS OF DEVELOPMENT AND COURSE OF MYOCARDIAL INFARCTION IN SMOKERS AND NON-SMOKERS
43-48
S.B. Fitilev, I.I. Shkrebneva, A.V. Vozzhaev, K.O. Tsukanova, D.A. Dimitrovа
TRENDS IN THE USE OF ANTI-ANGINAL PREPARATIONS IN THE SPECIALIZED OUTPATIENT CLINIC FOR THE FIVE-YEAR PERIOD
49-54
M.V. Ezhov, E.V. Sorokin
SAFETY AND EFFICACY OF LONG-TERM THERAPY WITH HIGH DOSES OF ATORVASTATIN
55-60
O.D. Ostroumova (1, 2), Т.М. Ostroumova (2), E.V. Borisova (3), V.A. Perepelov (2)
CEREBROPROTECTIVE EFFECTS OF FIXED-DOSE COMBINATION OF PERINDOPRIL ARGININE/INDAPAMIDE
61-67
V.Ya. Dzerve
ENERGY METABOLISM CORRECTOR MILDRONATE®: INTERRELATION OF MECHANISMS OF ACTION AND THERAPEUTIC EFFECTS
68-73
I.T. Murkamilov (1, 2), K.A. Aitbayev (3), V.V. Fomin (4), Z.R. Rayimzhanov (5), N.A. Redzhapova (6), F.A. Yusupov (6), Z.A. Aydarov (1)
SUPPRESSION OF PROGRESSION OF RENAL DYSFUNCTION AND CEREBROVASCULAR EVENTS: POTENTIALS OF ATORVASTATIN
74-82
V.D. Makarova (1), M.R. Egiyan (1), E.A. Orlov (1), I Sun Cher (2), V.A. Dadaeva (3), A.Yu. Os’kova (1), E.S. Akarachkova (4), A.S. Orlova (1), E.V. Silina (1)
IMPORTANCE OF INCREASING AWARENESS OF CHILDREN AND ADOLESCENTS ABOUT RISK FACTORS AND THE main SYMPTOMS OF THE STROKE
83-87
By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.